Column Group Management LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 276,630 shares at $12.41 ($3.9M) on 2020-04-03, disclosed to the SEC on 2020-04-07.
Open-market purchase of $3.9M NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.41 | 14,587 | $181K | 4.6% |
| 2 | $12.41 | 14,587 | $181K | 4.6% |
| 3 | $14.38 | 123,728 | $1.8M | 45.4% |
| 4 | $14.38 | 123,728 | $1.8M | 45.4% |
| Total | $14.17 avg | 276,630 | $3.9M | 100% |
| Filing → |
| NGM | BUY | 2019-11-06 | $202K | — | Filing → |
| NGM | BUY | 2019-08-05 | $61K | — | Filing → |
| NGM | BUY | 2019-04-10 | $30.2M | — | Filing → |